细分医药 (000814.SH) Stock Community - Hot Topic Discussions - Longbridge

For Institutions
Download
Help
About

Markets

Information

Affiliate Program

Promotions

EN

English

简体中文

繁體中文

繁體中文（廣東話）Posts & comments will be shown in Cantonese

Search...

Quote List Quote List

© 2025 Longbridge｜Disclaimer

Event Tracking

Dec14

Description of 2025 China Enterprise Science and Technology Innovation Power Ranking in Wholesale and Retail Industry

11:07

Junshi Biosciences' EGFR/HER3 Bispecific Antibody-Drug Conjugate JS212 Clinical Trial Approved by FDA

07:49

Dec13

2025 National Medical Insurance Drug Directory Update, Hengrui and Eli Lilly are Major Winners

03:47

Macquarie Analyst Maintains Buy Rating on BeiGene

01:12

Dec12

Hengrui Medicine's Subsidiary Receives Clinical Trial Approval Notice for RSS0343 Tablets from NMPA

11:57

HRS9531 Injection Approved for Clinical Trials by Huahai Medicine's Subsidiary

11:53